CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 178 filers reported holding CRISPR THERAPEUTICS AG in Q1 2019. The put-call ratio across all filers is 1.73 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $609,000 | +48.5% | 10,000 | 0.0% | 0.41% | +31.4% |
| Q3 2019 | $410,000 | -13.0% | 10,000 | 0.0% | 0.32% | -2.8% |
| Q2 2019 | $471,000 | +31.9% | 10,000 | 0.0% | 0.32% | +27.1% |
| Q1 2019 | $357,000 | +24.8% | 10,000 | 0.0% | 0.26% | +0.4% |
| Q4 2018 | $286,000 | -35.6% | 10,000 | 0.0% | 0.25% | -12.4% |
| Q3 2018 | $444,000 | -24.5% | 10,000 | 0.0% | 0.29% | -30.5% |
| Q2 2018 | $588,000 | +28.7% | 10,000 | 0.0% | 0.42% | +20.2% |
| Q1 2018 | $457,000 | -35.1% | 10,000 | -66.7% | 0.35% | -37.4% |
| Q4 2017 | $704,000 | – | 30,000 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $32,581,000 | 55.55% |
| NEA Management Company, LLC | 1,590,002 | $103,907,000 | 5.19% |
| ARK Investment Management | 8,237,122 | $538,296,000 | 3.75% |
| Nikko Asset Management Americas, Inc. | 4,262,736 | $277,078,000 | 3.54% |
| CLOUGH CAPITAL PARTNERS L P | 414,767 | $27,105,000 | 2.89% |
| Integral Health Asset Management, LLC | 220,000 | $14,377,000 | 2.79% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,268,000 | 2.48% |
| HC Advisors, LLC | 53,944 | $3,525,000 | 2.43% |
| Green Alpha Advisors, LLC | 27,466 | $1,795,000 | 1.52% |
| EFG Asset Management (North America) Corp. | 84,356 | $5,516,000 | 1.28% |